ArticleMedicine2026
Integrating ISAR and CIRS with ED triage to predict 30-day adverse outcomes in older adults: Development and internal validation of a dual-scale model.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Older emergency department (ED) patients are at significant risk of experiencing composite adverse outcomes such as ED revisits, intensive care unit admissions, and all-cause mortality within a short period. Existing predictive tools primarily utilize single scoring systems, showing limited predictive accuracy and clinical applicability. This study evaluated whether combining the identification of seniors at risk (ISAR) and the cumulative illness rating scale (CIRS) with routinely available ED triage information could provide incremental predictive value for 30-day composite adverse outcomes among older ED patients in China, compared with single-scale and clinical-variable models. A prospective, single-center cohort study was conducted involving older patients aged ≥ 65 years attending a tertiary hospital ED in China from March to May 2024. ISAR and CIRS assessments, along with baseline clinical data, were collected upon ED admission. The primary outcome was a composite adverse event within 30 days, including ED revisit, intensive care unit admission, or death. Variable selection was performed using least absolute shrinkage and selection operator regression. Logistic regression models, including single-scale, combined ISAR + CIRS, and baseline clinical models, were constructed and compared based on discrimination, calibration, and clinical net benefit through decision curve analysis. Model interpretability was further evaluated using analyses. A total of 607 older patients were enrolled, with 216 (35.6%) experiencing composite adverse outcomes within 30 days. The combined ISAR + CIRS model showed the highest area under the curve (AUC) among the compared models (AUC = 0.807; 95% confidence interval [CI]: 0.776-0.839), with a statistically significant improvement over the ISAR-based model (AUC = 0.793; 95% CI: 0.761-0.826). However, the absolute improvement compared with the CIRS-based model was small (AUC = 0.805; 95% CI: 0.773-0.837). The combined model showed favorable calibration and higher net benefit across clinically relevant thresholds. extreme gradient boosting and SHapley Additive exPlanations analyses suggested that ISAR, CIRS, systolic blood pressure, triage level, and pulse rate were important contributors to model output. The combined ISAR + CIRS model provided an interpretable and clinically feasible approach for early risk stratification of older ED patients. Although the improvement in discrimination was modest, integrating acute geriatric risk assessment and chronic comorbidity burden may support more comprehensive risk evaluation alongside routine ED triage and clinical judgment. Further external validation is needed before broader clinical implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.